These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30790234)

  • 1. Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience.
    Scalvenzi M; Patrì A; Costa C; Megna M; Napolitano M; Fabbrocini G; Balato N
    Dermatol Ther (Heidelb); 2019 Jun; 9(2):369-372. PubMed ID: 30790234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
    Remling R; Mempel M; Schnopp N; Abeck D; Ring J
    Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of keratoacanthoma: Is intralesional methotrexate an option?
    Patel NP; Cervino AL
    Can J Plast Surg; 2011; 19(2):e15-8. PubMed ID: 22654538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
    Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
    Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional interferon alfa-2b treatment of keratoacanthomas.
    Oh CK; Son HS; Lee JB; Jang HS; Kwon KS
    J Am Acad Dermatol; 2004 Nov; 51(5 Suppl):S177-80. PubMed ID: 15577764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: case report and review of a controversial therapy.
    Sanders S; Busam KJ; Halpern AC; Nehal KS
    Dermatol Surg; 2002 Oct; 28(10):954-8. PubMed ID: 12410683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Chitwood K; Etzkorn J; Cohen G
    Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative Efficacy of Nonoperative Treatment of Keratoacanthomas.
    Seger EW; Tarantino IS; Neill BC; Wang T
    J Cutan Med Surg; 2020; 24(1):41-46. PubMed ID: 31591899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intralesional methotrexate for the treatment of keratoacanthoma: retrospective study and review of the korean literature.
    Yoo MG; Kim IH
    Ann Dermatol; 2014 Apr; 26(2):172-6. PubMed ID: 24882970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
    Moss M; Weber E; Hoverson K; Montemarano AD
    Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional methotrexate in dermatology: Diverse indications and practical considerations.
    Searle T; Ali FR; Al-Niaimi F
    Dermatol Ther; 2021 Jan; 34(1):e14404. PubMed ID: 33044042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil.
    Parker CM; Hanke CW
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):770-7. PubMed ID: 3711381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Intralesional Methotrexate in the Treatment of a Large Keratoacanthoma of the Dorsal Hand in a 99-Year-Old Woman.
    Della Valle V; Milani M
    Case Rep Dermatol; 2018; 10(3):247-250. PubMed ID: 30519171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of keratoacanthomas with intralesional fluorouracil.
    Odom RB; Goette DK
    Arch Dermatol; 1978 Dec; 114(12):1779-83. PubMed ID: 736584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
    Sayan A; Taibjee S; Ilankovan V
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
    Hoegler KM; Schleichert RA
    J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.